Moderna, Inc. (BVMF:M1RN34)

Market Cap	69.94B
Revenue (ttm)	11.90B
Net Income (ttm)	-16.61B
Shares Out	n/a
EPS (ttm)	-42.91
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,738
Average Volume	53,860
Open	8.59
Previous Close	8.38
Day's Range	8.59 - 9.43
52-Week Range	6.02 - 14.89
Beta	1.11
RSI	62.68
Earnings Date	Feb 20, 2026

About Moderna

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, su...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 5,800
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: M1RN34

Financial Performance

In 2024, Moderna's revenue was $3.24 billion, a decrease of -52.75% compared to the previous year's $6.85 billion. Losses were -$3.56 billion, -24.46% less than in 2023.

Financial numbers in USD